The increase in the number of PFN1-expressing CTCS in HNSCC patients with lymph node metastases and the dependence of the number of CAP1-containing CTCs on the histotype of the primary tumor may be associated with the acquisition of functional features of CTCs during the progression of HNSCC. This evidence concerns the gene CAP1 and metastatic malignant neoplasm in the lymph nodes.